769119-47-3

Upstream product

• 811450-82-5 4-(2-(2-chloroethoxy)acetamido)1-nitrobenzene 
• 100-01-6 4-nitro-aniline 
• 16937-99-8 N-Boc-D-Leu 
• 697284-64-3 (R)-{3-methyl-1-[4-(3-oxo-morpholin-4-yl)-phenylcarbamoyl]-butyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa

Neutral chlorothiophenecarboxamides bearing an amino acid and a substituted aniline were synthesized and investigated for their factor Xa inhibitory activity in vitro. From selected 2-methylphenyl morpholinones the solution properties were determined. The most soluble and active compounds were then investigated in different animal species to compare the pharmacokinetic parameters. This led to a potent, water soluble and orally bioavailable candidate for further development: EMD 495235.